ATOSSA THERAPEUTICS INC's ticker is ATOS and the CUSIP is 04962H506. A total of 25 filers reported holding ATOSSA THERAPEUTICS INC in Q3 2020. The put-call ratio across all filers is 0.45 and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $158,084 | -41.5% | 214,642 | 0.0% | 0.00% | – |
Q2 2023 | $270,449 | +73.1% | 214,642 | -0.4% | 0.00% | – |
Q1 2023 | $156,199 | +34.2% | 215,476 | -2.2% | 0.00% | – |
Q4 2022 | $116,399 | -36.4% | 220,244 | 0.0% | 0.00% | – |
Q3 2022 | $183,000 | -23.4% | 220,244 | +0.6% | 0.00% | – |
Q2 2022 | $239,000 | -81.0% | 218,959 | -78.3% | 0.00% | – |
Q1 2022 | $1,259,000 | -25.0% | 1,006,950 | -4.1% | 0.00% | – |
Q4 2021 | $1,679,000 | -52.4% | 1,049,488 | -3.1% | 0.00% | -100.0% |
Q3 2021 | $3,529,000 | -50.3% | 1,082,518 | -3.7% | 0.00% | 0.0% |
Q2 2021 | $7,104,000 | +2214.0% | 1,123,852 | +671.6% | 0.00% | – |
Q1 2021 | $307,000 | +2970.0% | 145,648 | +1258.5% | 0.00% | – |
Q4 2020 | $10,000 | -61.5% | 10,721 | 0.0% | 0.00% | – |
Q3 2020 | $26,000 | -36.6% | 10,721 | 0.0% | 0.00% | – |
Q2 2020 | $41,000 | +141.2% | 10,721 | -14.4% | 0.00% | – |
Q1 2020 | $17,000 | -15.0% | 12,529 | 0.0% | 0.00% | – |
Q4 2019 | $20,000 | -20.0% | 12,529 | 0.0% | 0.00% | – |
Q3 2019 | $25,000 | – | 12,529 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
SABBY MANAGEMENT, LLC | 362,072 | $453,000 | 0.07% |
GSA CAPITAL PARTNERS LLP | 66,223 | $83,000 | 0.01% |
Aquatic Capital Management LLC | 4,400 | $6,000 | 0.01% |
D. E. Shaw & Co., Inc. | 3,863,135 | $4,829,000 | 0.01% |
Spire Wealth Management | 94,000 | $118,000 | 0.00% |
SUSQUEHANNA FUNDAMENTAL INVESTMENTS, LLC | 111,898 | $140,000 | 0.00% |
Renaissance Technologies | 2,100,492 | $2,626,000 | 0.00% |
ALPS ADVISORS INC | 130,141 | $163,000 | 0.00% |
Cutler Group LLC / CA | 21,400 | $30,000 | 0.00% |
TWO SIGMA ADVISERS, LP | 681,600 | $852,000 | 0.00% |